Lucy Carty

Affiliations

Medical and Payer Evidence Statistics, BioPharmaceuticals Medical, AstraZeneca, Cambridge, United Kingdom.

Réseau de co-auteurs

Sylvia Taylor 2 collaborations

Rachael A Evans 1 collaboration

Sabada Dube 1 collaboration

Yi Lu 1 collaboration

Mark Yates 1 collaboration

Sofie Arnetorp 1 collaboration

Eleanor Barnes 1 collaboration

Samira Bell 1 collaboration

Kathryn Evans 1 collaboration

Sophie Graham 1 collaboration

Nahila Justo 1 collaboration

Paul Moss 1 collaboration

Sudhir Venkatesan 1 collaboration

Renata Yokota 1 collaboration

Catia Ferreira 1 collaboration

Richard McNulty 1 collaboration

Jennifer K Quint 1 collaboration

Joseph Makhema 1 collaboration

Emily Shava 1 collaboration

Alane Izu 1 collaboration

Tendani Gaolathe 1 collaboration

Lesego Kuate 1 collaboration

Adam Walker 1 collaboration

Panayiotis Georgiou 1 collaboration

Coulson Kgathi 1 collaboration

Wonderful T Choga 1 collaboration

Tumalano Sekoto 1 collaboration

Ngozana Seonyatseng 1 collaboration

Tuelo Mogashoa 1 collaboration

Comfort N Maphorisa 1 collaboration

Terence Mohammed 1 collaboration

Tshenolo Ntalabgwe 1 collaboration

Tshepho T Frank 1 collaboration

Boitumelo Matlhaku 1 collaboration

Ame Diphoko 1 collaboration

Thandie Phindela 1 collaboration

Agripa Kaunda 1 collaboration

Poloko Kgari 1 collaboration

Thomas Kanyakula 1 collaboration

Gape Palalani 1 collaboration

Isabella Phakedi 1 collaboration

Mompati Mmalane 1 collaboration

Sikhulile Moyo 1 collaboration

Lucy Carty

Affiliations

Publications (2)

Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study.

Safety of AZD1222 COVID-19 vaccine and low Incidence of SARS-CoV-2 infection in Botswana following ChAdOx1(AZD1222) vaccination: A single-arm open-label interventional study - final study results.

Réseau de co-auteurs